Abbott India submits board meeting intimation

28 Jan 2025 Evaluate
In terms of Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday February 5, 2025, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2024. Further, in terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and further to intimation dated December 23, 2024, the Trading Window of the Company remains closed from Wednesday, January 1, 2025 to Friday, February 7, 2025.

The above information is a part of company’s filings submitted to BSE.

Abbott India Share Price

28871.70 255.30 (0.89%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×